The TROPION-Breast02 trial is the first to show overall survival benefit in this patient population, indicating a potential ...
October 2025 Datroway demonstrated statistically significant and clinically meaningful improvement in overall survival as 1st-line therapy for patients with metastatic triple-negative breast cancer ...
The U.S. Food and Drug Administration (FDA) has granted priority review and breakthrough therapy designation to the ...
The FDA has approved the combination of lurbinectedin (Zepzelca) and atezolizumab (Tecentriq) as a first-line maintenance treatment for patients with extensive-stage small cell lung cancer (ES-SCLC) ...
It is largely due to advances in treatment that there are now more than 220,000 people in Ireland living with or after cancer ...
October is Breast Cancer Awareness Month, and CURE is here to address some of the most common questions patients have after a ...
Detailed price information for Astrazeneca Plc ADR (AZN-Q) from The Globe and Mail including charting and trades.
Jayme Steighner was gathering her husband and two daughters for a photograph in front of the touristy Pineapple Fountain in ...
The Phase III TROPION-Breast02 trial demonstrated that datopotamab deruxtecan (Datroway) achieved a statistically significant ...
Canaccord Genuity has updated its long-term (from 2029) gold price forecast by 8.2% to US$4,173/oz, and the medium-term ...
WE OFTEN think of chemotherapy as treatment given after surgery to destroy remaining cancer cells. While this is not ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback